DFEMX Congressional Stock Trades
DFA EMERGING MARKETS
Last disclosed trade Oct 1
Every disclosed trade in DFEMX by members of Congress under the STOCK Act, parsed by Coldpine. Informational only, sourced from public filings. Not investment advice.
Sample · the intelligence layer
Michael T. McCaul · Bought $DFEMX · Dec 13 · $1K–$15K
Managed-account penalty applied (x 0.20): filings dominated by trust or wealth-manager activity are discounted.
Every disclosed trade in the database gets this treatment: a four-factor score and a written read from Coldpine’s AI-based analysis. Informational only, not investment advice. Create a free account for every scored trade →
Follow $DFEMX
Get notified when any member of Congress trades $DFEMX. Free, no card, no spam.
The record on $DFEMX
Coldpine has parsed 7 disclosed trades in $DFEMX by 1 member of Congress, drawn from 5 periodic transaction reports dated Dec 13, 2023 through Oct 1, 2025. All of them came from House members, all filed by Republicans.
Of the 7 trades with a known filing lag, every one was reported inside the STOCK Act's 45-day window. The median lag was 40 days. The longest was 45 days: a $DFEMX purchase by Michael T. McCaul dated Jul 1, 2024, disclosed Aug 15, 2024. How late filing is measured across all of Congress is in the late-filers study.
4 of the 7 trades that list an account holder (57%) were reported under a spouse, dependent child, or joint account rather than the member directly.
Activity peaked in 2024 with 4 trades.
Members who trade DFEMX
Recent disclosed trades in DFEMX
| Date | Member | Type | Amount |
|---|---|---|---|
| Oct 1 | Michael T. McCaul(TX) | buy | $1K–$15K |
| Apr 1 | Michael T. McCaul(TX) | buy | $1K–$15K |
| Jul 1 | Michael T. McCaul(TX) | buy | $1K–$15K |
| Jul 1 | Michael T. McCaul(TX) | buy | $1K–$15K |
| Apr 1 | Michael T. McCaul(TX) | buy | $1K–$15K |
| Apr 1 | Michael T. McCaul(TX) | buy | $1K–$15K |
| Dec 13 | Michael T. McCaul(TX) | buy | $1K–$15K |
Data sourced from public STOCK Act disclosures. Coldpine is a publisher of intelligence on congressional disclosures, not an investment adviser. See full history and scores, free with an account →